Related references
Note: Only part of the references are listed.Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection
Annabel Werumeus Buning et al.
ANTIBIOTICS-BASEL (2021)
Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance
Gemma Martinez-Nadal et al.
CLINICAL INFECTIOUS DISEASES (2020)
Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa
Pier Giorgio Cojutti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
C. Lacroix et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
MIC-based dose adjustment: facts and fables
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents
Sameer S. Kadri et al.
CLINICAL INFECTIOUS DISEASES (2018)
Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance
Carolina Garcia-Vidal et al.
PLOS ONE (2018)
Therapeutic drug monitoring of beta-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures
Gloria Wong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
E. M. Trecarichi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact
Enrico M. Trecarichi et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams
Joao Goncalves-Pereira et al.
CRITICAL CARE (2011)
High-Dose Continuous Infusion β-Lactam Antibiotics for the Treatment of Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients
Brad Moriyama et al.
ANNALS OF PHARMACOTHERAPY (2010)
Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation
Desiree Caselli et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Cephalosporin-Induced Neurotoxicity: Clinical Manifestations, Potential Pathogenic Mechanisms, and the Role of Electroencephalographic Monitoring
Marie Francisca Grill et al.
ANNALS OF PHARMACOTHERAPY (2008)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Share Paper
